What is the adiponectin receptor?

Adiponectin is an adipokin, a type of hormone produced by fat cells that helps regulate energy metabolism. As a result, the body is more sensitive to insulin, a hormone that promotes the movement of glucose from blood to cells and helps reduce the risk of diabetes and narrow the arteries. The adiponectin receptor is a protein found on cells in many areas of the body, including oily tissue, muscles, liver and brain. There are two types of adiponectin receptor, known as Adipor1 and Adipor2, to which adiponectin binds, causing changes inside cells. Adiponectin and circulating adiponectin levels can be changed in conjunction with conditions such as obesity and diabetes. It also counteracts the state known as insulin resistance, where insulin becomes less effective in moving glucose to cells and prevents heterglucose. Insulin resistance is associated with obesity and diabetes and tempered arteries or atherosclerosis. It is assumed that too much body fat can reduce the number of adiponect receptorsWell, so cells are less responding to adiponectin, which could lead to insulin resistance. On the other hand, weight loss could lead to an increase in adiponectin receptor levels, reversing insulin resistance.

Adiponectin receptor Adipor1 is found mainly in skeletal muscles, while adipor2 is mostly present in the liver. In fat cells in the human body, Adipor1 is the type of adiponectin receptor that is most common. Adiponectin exists in two versions, each of which is different from two types of receptors. It is assumed that Adipor1 is very well bound to what is called the globular form of adiponectin, but less well on the full length version, while adipor2 is slightly well bound by the two forms. The development of drugs that follow up to adiponectin receptors and mimics the effect of adiponectin or that increase the number of receptors could provide useful methods of treatment for the disease associatedWith insulin resistance such as diabetes.

The

growth hormone, which is produced by pituitary glands, has been found to affect the adiponectin adipor2 receptor. Scientists have noted that elevated levels of growth hormone are associated with an increase in the number of adipor2 receptors in some fat cells. This suggests that the growth hormone contributes to changes in the sensitivity of insulin and metabolism of the body's energy.